LCM
TBPH icon

Laurion Capital Management’s Theravance Biopharma TBPH Stock Holding History

Laurion Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,095
Closed -$201K – 729
2021
Q3 		$201K Sell
27,095
-1,067,841
-98% -$11.9M ﹤0.01% 633
2021
Q2 		$15.9M Buy
1,094,936
+390,328
+55% +$7.33M 0.09% 167
2021
Q1 		$14.4M Buy
704,608
+63,373
+10% +$1.2M 0.08% 210
2020
Q4 		$11.4M Buy
641,235
+621,754
+3,192% +$11.2M 0.09% 176
2020
Q3 		$288K Sell
19,481
-224,990
-92% -$4.21M ﹤0.01% 681
2020
Q2 		$5.13M Sell
244,471
-55,529
-19% -$1.43M 0.06% 223
2020
Q1 		$6.93M Buy
300,000
+222,472
+287% +$5.57M 0.08% 206
2019
Q4 		$2.01M Buy
+77,528
New +$1.51M 0.02% 448
2018
Q3 		– Sell
-61,110
Closed -$1.39M – 1527
2018
Q2 		$1.39M Sell
61,110
-219,945
-78% -$5.22M 0.01% 697
2018
Q1 		$6.82M Buy
+281,055
New +$7.72M 0.05% 300
2014
Q4 		– Sell
-74,370
Closed -$1.71M – 418
2014
Q3 		$1.71M Sell
74,370
-50,502
-40% -$1.47M 0.04% 164
2014
Q2 		$3.98M Buy
+124,872
New +$3.76M 0.08% 179

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Laurion Capital Management's TBPH Position: Q4 2021 in Review

Laurion Capital Management sold out of Theravance Biopharma (TBPH) in Q4 2021, closing a stake of 27,095 shares — an estimated $201K sold.

Laurion Capital Management first reported a position in TBPH in Q2 2014 and held it in 12 quarters. The position peaked at $15.9M in Q2 2021. 116 funds tracked by Wall St. Rank hold TBPH as of Q4 2021.

  • Laurion Capital Management reported no remaining Theravance Biopharma position as of Q4 2021 after selling out during the quarter.
  • Laurion Capital Management sold 27,095 Theravance Biopharma shares in Q4 2021, an estimated $201K.
  • Laurion Capital Management first reported a position in Theravance Biopharma in Q2 2014 and held it in 12 quarters.
  • Laurion Capital Management's Theravance Biopharma position peaked at $15.9M in Q2 2021.
  • 116 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2021.

Based on Laurion Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.